Patents by Inventor Jean-Louis Dasseux

Jean-Louis Dasseux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 11969456
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: August 4, 2023
    Date of Patent: April 30, 2024
    Assignee: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • APOMERS
    Publication number: 20240123027
    Abstract: Apomers comprising apolipoprotein molecules complexed with amphipathic molecules and uses thereof for treating dyslipidemic and liver disorders.
    Type: Application
    Filed: July 28, 2023
    Publication date: April 18, 2024
    Applicant: ABIONYX PHARMA SA
    Inventor: Jean-Louis DASSEUX
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20240016824
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: July 21, 2023
    Publication date: January 18, 2024
    Applicant: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20240000887
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 4, 2024
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20230372441
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: August 4, 2023
    Publication date: November 23, 2023
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Charged lipoprotein complexes and their uses
    Patent number: 11801282
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: October 31, 2023
    Assignee: Abionyx Pharma SA
    Inventor: Jean-Louis Dasseux
  • CER-001 therapy for treating kidney disease
    Patent number: 11752163
    Abstract: Disclosed herein is the use of CER-001, a negatively charged lipoprotein complex which comprises recombinant human apolipoprotein A-I (ApoA-I), sphingomyelin (SM), and 1,2-dihexadecanoyl-sn-glycero-3-phospho-(1?-rac-glycerol) (Dipalmitoylphosphatidyl-glycerol; DPPG) for treating kidney diseases, and methods for treating a subject having kidney diseases with CER-001. For example, the kidney disease can be associated with a lecithin cholesterol acyl transferase (LCAT) deficiency.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: September 12, 2023
    Assignee: Abionyx Pharma SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20220362336
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: May 27, 2022
    Publication date: November 17, 2022
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 11376309
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: July 5, 2022
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • CER-001 THERAPY FOR TREATING KIDNEY DISEASE
    Publication number: 20210322448
    Abstract: CER-001 for treating kidney disease, and methods for treating a subject having kidney disease with CER-001.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Applicant: ABIONYX PHARMA SA
    Inventors: Jean-Louis Dasseux, Laura Calabresi, Cyrille Tupin, Ronald Barbaras, Constance Peyrottes
  • APOMERS
    Publication number: 20210145932
    Abstract: Apomers comprising apolipoprotein molecules complexed with amphipathic molecules and uses thereof for treating dyslipidemic and liver disorders.
    Type: Application
    Filed: June 29, 2020
    Publication date: May 20, 2021
    Applicant: ABIONYX PHARMA SA
    Inventor: Jean-Louis DASSEUX
  • LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF
    Publication number: 20190298800
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Application
    Filed: April 29, 2019
    Publication date: October 3, 2019
    Applicant: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis DASSEUX, Rose ACKERMANN, Daniela Carmen ONICIU
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 10328119
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: June 25, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • Lipoprotein complexes and manufacturing and uses thereof
    Patent number: 10322163
    Abstract: The present disclosure relates to lipoprotein complexes and lipoprotein populations and their use in the treatment and/or prevention of dyslipidemic diseases, disorders, and/or conditions. The disclosure further relates to recombinant expression of apolipoproteins, purification of apolipoproteins, and production of lipoprotein complexes using thermal cycling-based methods.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: June 18, 2019
    Assignee: CERENIS THERAPEUTICS HOLDING S.A.
    Inventors: Jean-Louis Dasseux, Rose Ackermann, Daniela Carmen Oniciu
  • APOMERS
    Publication number: 20190046608
    Abstract: Apomers comprising apolipoprotein molecules complexed with amphipathic molecules and uses thereof for treating dyslipidemic and liver disorders.
    Type: Application
    Filed: August 10, 2018
    Publication date: February 14, 2019
    Applicant: CERENIS THERAPEUTICS HOLDING SA
    Inventor: Jean-Louis DASSEUX
  • CARGOMERS
    Publication number: 20190048049
    Abstract: Cargomers comprising apolipoprotein molecules complexed with amphipathic molecules and one or more cargo moieties.
    Type: Application
    Filed: August 10, 2018
    Publication date: February 14, 2019
    Applicant: CERENIS THERAPEUTICS HOLDING SA
    Inventor: Jean-Louis DASSEUX
  • HDL THERAPY MARKERS
    Publication number: 20180203025
    Abstract: The present application relates to companion diagnostic assays for therapeutic agents that mimic HDL or elevate HDL expression levels. The present application also related to methods of treatment of familial hypoalphalipoproteinemias.
    Type: Application
    Filed: March 7, 2018
    Publication date: July 19, 2018
    Applicant: Cerenis Therapeutics Holding SA
    Inventors: Jean-Louis DASSEUX, Ronald BARBARAS
  • Apolipoprotein A-I mimics
    Patent number: 9981008
    Abstract: Provided are peptides, compositions thereof, and methods for treating or preventing dyslipidemia, a cardiovascular disease, endothelial dysfunction, a macrovascular disorder, or a microvascular disorder.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: May 29, 2018
    Assignee: Cerenis Therapeutics Holding SA
    Inventors: Jean-Louis Dasseux, Anna Shenderova Schwendeman, Lingyu Zhu
  • CHARGED LIPOPROTEIN COMPLEXES AND THEIR USES
    Publication number: 20170182121
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Application
    Filed: January 4, 2017
    Publication date: June 29, 2017
    Applicant: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis DASSEUX
  • Charged lipoprotein complexes and their uses
    Patent number: 9567388
    Abstract: The present disclosure provides charged lipoprotein complexes that include as one component a negatively charged phospholipid that is expected to impart the complexes with improved therapeutic properties.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: February 14, 2017
    Assignee: Cerenis Therapeutics Holding S.A.
    Inventor: Jean-Louis Dasseux